Toronto Dominion Bank
MRTX

Toronto Dominion Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Toronto Dominion Bank’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$1.49M – 1884
2023
Q1 		$1.49M Buy
+40,000
New +$1.8M ﹤0.01% 938
2022
Q4 		– Sell
-18,672
Closed -$1.3M – 1623
2022
Q3 		$1.3M Buy
+18,672
New +$1.38M ﹤0.01% 1014

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Toronto Dominion Bank's MRTX Position: Q2 2023 in Review

Toronto Dominion Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 40,000 shares — an estimated $1.49M sold.

Toronto Dominion Bank first reported a position in MRTX in Q3 2022 and held it in 2 quarters. The position peaked at $1.49M in Q1 2023. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

  • Toronto Dominion Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 40,000 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.49M.
  • Toronto Dominion Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Toronto Dominion Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $1.49M in Q1 2023.
  • 207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Toronto Dominion Bank's 13F filing for Q2 2023, filed 10 Aug 2023.